Targeting HMGA1-driven leukemic transformation in myeloproliferative neoplasms with pacritinib
Can Yang(Huashan Hospital), Zhiyuan Wu(Tulane University), Zhen Huang(China Pharmaceutical University), Ming Guan(Fudan University), Xuemei Tang(University of Electronic Science and Technology of China), Wenjiao Qin(Fudan University), Yajun Li(Xi'an Medical University), Wenhao Zhang(South China Agricultural University), Yu Zeng(Tongji University), Xiaotong Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Qingyun Zhang(Jiangsu University), Wenshu Zheng(Southern University of Science and Technology), Kun Chen(Sun Yat-sen University), Gusheng Tang(Naval Medical Research Command), Jianfei Fu(Jinhua Central Hospital)
Cited by 1
Related Papers
Increased temperature and precipitation interact to affect root production, mortality, and turnover in a temperate steppe: implications for ecosystem C cycling
|Global Change Biology|2009|225
Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells
|International Journal of Cancer|2019|213
Identification of Bacteria in Water by a Fluorescent Array
|Angewandte Chemie International Edition|2014|178
Composites of Bacterial Cellulose and Small Molecule-Decorated Gold Nanoparticles for Treating Gram-Negative Bacteria-Infected Wounds
|Small|2017|168
Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection
|Cell Reports|2020|164